Latest Breaking News On - Biologically active copolymer - Page 1 : comparemela.com

SYDNEY, Australia, Aug. 04, 2023 (GLOBE NEWSWIRE) Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the Australian Patent Office has formally granted Recce a new family four patent, “Process for Preparation of Biologically Active Copolymer,” with expiry in 2041. “We are thrilled to receive this new family of intellectual property, granted by the Australian Patent Office, with further market monopolies reinfo

United statesCross riverNew south walesAndrew geddesJordyn temperatoJames grahamAustralian patent officeRecce pharmaceuticalsLifesci communicationsRecce pharmaceuticals ltdPharmaceuticals ltdBiologically active copolymerChief executive officerAustralian patentPatent cooperation treaty countryPathogens covered